This was examined on Smad3+/+ mice bearing B16F10 or LLC tumours by inactivating Smad3 signalling with an inhibitor SIS3 that specifically blocks the phosphorylation and DNA binding of Smad3 proteins29. The gene discussed is SMAD3; the disease is neoplasm.